INFO:

AstraZeneca Chief Financial Officer Aradhana Sarin discusses first-quarter earnings, implications of the US Inflation Reduction Act and the outlook for the company's commercial business in China. She spoke on Bloomberg Television after AstraZeneca's profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu. (Source: Bloomberg)